• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与组织型纤溶酶原激活剂诱导的蛋白水解活性相关的纤维蛋白凝块结构变化。一项核磁共振研究。

Structural changes in fibrin clot associated with the proteolytic activity induced by tissue type plasminogen activator. An NMR study.

作者信息

Azoury R, Bitton M, Abrashkin S, Lavie E

机构信息

Radiopharmaceuticals Department, Soreq Nuclear Research Center, Yavne, Israel.

出版信息

Biochim Biophys Acta. 1989 May 1;995(3):295-300. doi: 10.1016/0167-4838(89)90050-2.

DOI:10.1016/0167-4838(89)90050-2
PMID:2495819
Abstract

The kinetic behavior of fibrin clot lysis as induced by tissue-type plasminogen activator (t-PA) was studied using proton magnetic resonance (PMR) and a release assay of fibrin labeled with technetium-99m isotope (99mTc). The lysis pattern of the preformed clot was examined as a function of gradual changes in the amounts of added t-PA and deactivated t-PA. The behavior of fibrinolysis was found to depend strongly on the amount of t-PA in the assay, which markedly affects the lysis rate of fibrin. The changes induced by the lysis were reflected in pronounced prolongation of the transverse relaxation time. The PMR and the radioisotope release measurements point to the possibility that at least two steps are involved in the mechanism of lysis. The PMR seems to be associated with structural features of the clot and reflects the liberation of compartmentalized water from the clot, while the 99mTc analysis reflects the further fragmentation of fibrin.

摘要

利用质子磁共振(PMR)和用锝-99m同位素(99mTc)标记的纤维蛋白释放试验,研究了组织型纤溶酶原激活剂(t-PA)诱导的纤维蛋白凝块溶解的动力学行为。将预先形成的凝块的溶解模式作为添加的t-PA和失活t-PA量的逐渐变化的函数进行检查。发现纤维蛋白溶解行为强烈依赖于试验中t-PA的量,这显著影响纤维蛋白的溶解速率。溶解引起的变化反映在横向弛豫时间的明显延长上。PMR和放射性同位素释放测量结果表明,溶解机制中至少涉及两个步骤。PMR似乎与凝块的结构特征有关,并反映了凝块中分隔水的释放,而99mTc分析反映了纤维蛋白的进一步碎片化。

相似文献

1
Structural changes in fibrin clot associated with the proteolytic activity induced by tissue type plasminogen activator. An NMR study.与组织型纤溶酶原激活剂诱导的蛋白水解活性相关的纤维蛋白凝块结构变化。一项核磁共振研究。
Biochim Biophys Acta. 1989 May 1;995(3):295-300. doi: 10.1016/0167-4838(89)90050-2.
2
Clot uptake of labeled active and inhibited tissue plasminogen activator.标记的活性及抑制性组织纤溶酶原激活剂的凝块摄取情况
Biochim Biophys Acta. 1989 Apr 25;991(1):62-7. doi: 10.1016/0304-4165(89)90029-9.
3
Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.不同纤溶酶对含表面活性剂纤维蛋白的裂解作用。表面活性的溶解动力学及恢复情况。
Am J Respir Cell Mol Biol. 1999 Dec;21(6):738-45. doi: 10.1165/ajrcmb.21.6.3514.
4
Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy.血浆凝块溶解过程中纤维蛋白网络的重排及纤溶成分的空间分布。共聚焦显微镜研究。
J Biol Chem. 1996 Jan 26;271(4):2133-8. doi: 10.1074/jbc.271.4.2133.
5
Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.组织型纤溶酶原激活剂和尿激酶原的互补作用模式,据此可解释它们对血栓溶解的协同效应。
J Clin Invest. 1988 Mar;81(3):853-9. doi: 10.1172/JCI113394.
6
A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.一种精确快速的微量滴定板凝块溶解测定法:纤维蛋白溶解过程中纤溶酶原激活的方法、动力学建模及催化常数测定
Thromb Haemost. 1990 Nov 30;64(3):455-63.
7
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶在体外血浆环境中对血凝块溶解不存在协同作用。
Thromb Haemost. 1986 Aug 20;56(1):35-9.
8
Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.通过测量组织因子诱导的凝块的溶解时间来评估纤维蛋白溶解活性:可行性评估。
Clin Appl Thromb Hemost. 2010 Jun;16(3):337-44. doi: 10.1177/1076029608325542. Epub 2008 Dec 30.
9
Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis.纤溶酶原激活物抑制剂-1对组织型纤溶酶原激活物诱导的纤维蛋白溶解的影响。
Thromb Haemost. 1992 Jan 23;67(1):106-10.
10
Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.可溶性纤维蛋白降解产物增强组织型纤溶酶原激活物诱导的纤维蛋白原蛋白水解作用。
J Clin Invest. 1991 Mar;87(3):1082-90. doi: 10.1172/JCI115069.